Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results - Wikidata - awgldk - TriplyDB

Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results

Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results

http://www.wikidata.org/entity/Q36764997

about

What are the current and potential future roles for endoscopic ultrasound in the treatment of pancreatic cancer?Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians Endoscopic ultrasound in the diagnosis and management of carcinoma pancreas Endoscopic ultrasound-fine needle injection for oncological therapy TNFerade, an innovative cancer immunotherapeutic Going viral: a review of replication-selective oncolytic adenoviruses Applications of endoscopic ultrasound in pancreatic cancer Current clinical trials testing the combination of immunotherapy with radiotherapy.Endoscopic ultrasound-guided therapies in pancreatic neoplasms.Chronic inflammation and cytokines in the tumor microenvironment.Intratumoural production of TNFα by bacteria mediates cancer therapy.The Development of a Minority Recruitment Plan for Cancer Clinical Trials.Combinations of immunotherapy and radiation in cancer therapy.Systematic review of novel ablative methods in locally advanced pancreatic cancer.Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings.Gene and cell therapy for pancreatic cancer.Modeling Combined Chemotherapy and Particle Therapy for Locally Advanced Pancreatic Cancer RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients.Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer Recombinant adenovirus-p53 (Gendicine) sensitizes a pancreatic carcinoma cell line to radiation.Targeting cell death signaling in colorectal cancer: current strategies and future perspectives.Endoscopy-guided ablation of pancreatic lesions: Technical possibilities and clinical outlook.Immunotherapeutic and oncolytic viral therapeutic strategies in pancreatic cancer.Gene therapy and imaging in preclinical and clinical oncology: recent developments in therapy and theranostics.Interventional endoscopic ultrasonography: Where are we headed?State-of-the-art endoscopic procedures for pancreatic cancer.Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction Endoscopic ultrasound in pancreatic cancer: innovative applications beyond the basics.Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.Interventional endoscopic ultrasonography.Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes.Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer.The role of Endoscopic Ultrasound (EUS) in the management of patients with pancreatic cancer: now bigger than ever.Biopharmaceuticals and gene vectors opening new avenues in cancer immune therapy.Endoscopic Ultrasound and Related Technologies for the Diagnosis and Treatment of Pancreatic Disease - Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control.Efficacy and Safety of Pancreas-Targeted Hydrodynamic Gene Delivery in Rats.A Novel Absorbable Radiopaque Hydrogel Spacer to Separate the Head of the Pancreas and Duodenum in Radiation Therapy for Pancreatic Cancer.Radiation therapy and immunotherapy: what is the optimal timing or sequencing?

P2860

Q26748562-8E55ED11-F24E-4BC7-810B-88A6FEEBAEC9 Q26767041-45A48AAA-7D7A-404B-BAC0-350D008C0CDA Q26770011-D7A1DAD4-858D-4A57-A805-19407AE95D35 Q26774086-537CFADE-FC09-484E-AC5D-73DA03EEA2E6 Q26776326-3636B24E-BCF9-45A9-ACF2-19998D290128 Q26797520-F5EEC860-3ACE-47D0-BC49-77F264932F5A Q26865612-C8B37A97-08D6-47D7-8D28-E499C76EFB2A Q30356447-98C1FF92-3B06-4EA0-94A9-F2606F2566BE Q30416211-2DBD3B70-32CD-4D56-832C-229E9C559582 Q33678275-8A4E2F8F-223B-405D-9EE3-2C828B0BBD49 Q33853333-9CAADC1A-B3D9-4168-9ACC-396C1F57219D Q34078645-D41AC090-1F78-49B2-84DE-61781E636580 Q34582640-095F471E-3031-40A9-89E3-49E05D43C0E3 Q35113615-CA250A14-E46D-40AC-B068-72BF255F242E Q35202400-8239DB59-54D7-4ACB-9812-7767BED5461E Q35399221-2F50296C-B6E5-4113-9E51-56B23182A3E7 Q35541787-DD8631FE-253E-4E57-88C5-C1E3128DCEF4 Q35820403-ADDE0E8A-BCCC-41FD-932B-A92CED6FBEED Q36414524-BAB62E76-A5FC-4431-A877-BC26FD5CC96C Q36842981-2BC7046E-9AB5-47E3-869E-165DBA1B49A7 Q37413649-C6DCF4CF-11AD-4723-AC10-A69178400196 Q37602717-CEE9AC1B-36F7-46D7-A54E-50A62BAB115C Q37644113-659DFFE4-0EF7-44AD-ABA2-59930990647F Q38221692-55F1BDAD-F249-4686-B2EA-33F321183EFD Q38297124-FE4A4835-ECDF-45D6-93B0-A999EB77A035 Q38759469-73339997-0BF0-4927-A2B8-040B89893384 Q38849083-38CC55BA-19D6-46A2-9835-6FA4F5B77751 Q38892371-A833C02A-57C5-4C29-ABA2-82C4EE58CBDC Q39025906-B685C212-47EB-483E-9BEE-3B15FAC1D614 Q39110839-161D8953-222C-4DCD-9B27-B799A1C86FEA Q39235720-E2978778-F7B8-4FD2-A5B0-9320F9BF407D Q39359422-B0A0BBA0-73AC-4AE2-81EE-9523B107D237 Q39462375-F18603AC-B552-46E2-A546-DB91E3D1A502 Q40073074-3C59A02B-C998-4AD8-950E-515410100E03 Q40655850-2D45469F-8A68-418B-92D3-EF5F89456C50 Q44815018-DBF2A10F-25BE-4FAD-B59F-FA32429064B9 Q46189367-6A3EB1E5-45E8-4E41-91D0-031C3EDE8161 Q46836744-D0C15A17-2D09-4E09-BF34-BA548216ED03 Q47931999-2A9E328B-8743-444C-84CB-8CB126C54549 Q50109474-F0E69F8E-C645-418C-899A-CAD0B05F1AB0

P2860

Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results

http://www.wikidata.org/entity/Q36764997

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Randomized phase III multi-ins ...... ncreatic cancer: final results

@ast

Randomized phase III multi-ins ...... ncreatic cancer: final results

@en

type

label

Randomized phase III multi-ins ...... ncreatic cancer: final results

@ast

Randomized phase III multi-ins ...... ncreatic cancer: final results

@en

prefLabel

Randomized phase III multi-ins ...... ncreatic cancer: final results

@ast

Randomized phase III multi-ins ...... ncreatic cancer: final results

@en

P1433

Q36764997-44D7A9C6-571F-49F7-BC9F-225EA46BC4D4

P1476

Q36764997-F681E745-B41A-46E0-9880-CA0C0D5478A8

P2093

Q36764997-1EC6317B-A3C3-405B-977D-9107B4E0853A

Q36764997-24973E8E-8A42-4A02-A3A7-1D584D81129E

Q36764997-2957B074-BA17-4DF1-A5E1-58424DA9685F

Q36764997-5C5E1A2A-923A-4EB0-813D-317434603906

Q36764997-5F2FB89D-9E13-43E3-85BE-A8E8E74CCA1D

Q36764997-8050ADA7-969C-4A0A-A1BA-CE87E13721C3

Q36764997-8492435C-D069-4C8E-B845-DF16AA1A6BF0

Q36764997-8C4FBC66-506F-4163-9694-EEB158498CE6

Q36764997-9B254A0F-9D20-4D7B-98F8-7D455A9FD57A

Q36764997-9FE44725-96CB-496C-92F4-8D663C9A0FBF

P2860

Q36764997-0194DCDD-32C5-4252-BCC2-FA459068126E

Q36764997-045CFB75-D8D0-4128-BE4A-89D679B28874

Q36764997-09888A86-9D82-46D6-80DF-CEA4AB85DEBC

Q36764997-0E77A32B-8108-4AC8-9457-A691D9523A69

Q36764997-1056D893-0A00-4A3D-90CD-62C7F9576231

Q36764997-1952D709-C01B-4860-B14C-09EAF8F630F1

Q36764997-1A8B9E71-B4B8-4B8D-B823-64C1CB1D7114

Q36764997-27900CD1-4F8F-49DC-843B-131E62B92337

Q36764997-29957ADB-D94A-4B2D-BEAA-2C50A29186E9

Q36764997-3EE0B0C5-E62C-4E9C-8BCD-B87881027553

P304

Q36764997-2B657AF4-B343-4A2A-A2A4-3B5D382E1E23

P31

Q36764997-5ED13981-09D5-4E1F-A67A-265ACC901945

P356

Q36764997-BF8E3895-D525-4056-ACFF-92F41A6C4704

P407

Q36764997-269B11C6-B0A0-4699-8F8F-5C9BDEA7E548

P433

Q36764997-EAB134FC-482C-471B-8D2F-0793AD2AE258

P478

Q36764997-2843F745-4729-4A51-8B5F-1D452ED0565D

P50

Q36764997-A038D1B5-19C0-499F-B6D6-CBCEE7A619BA

Q36764997-D71769DE-84A1-4622-853D-66103F5DDDEA

P577

Q36764997-7689B949-69A2-4B2E-AFB4-8118A0AF830A

P5875

Q36764997-1A6ED3BA-DBC7-45F0-825C-5E66359EE14D

P698

Q36764997-2D4F1C50-435E-4D77-9CAE-CFB2F6F0C6E5

P921

Q36764997-A8352CCF-E309-45DB-A8BB-A45A0AD9FECB

P932

Q36764997-85F554FD-BA15-4D74-90AA-BE1FCD6700BA

P356

JCO.2012.44.7516

P1433

Journal of Clinical Oncology

P1476

Randomized phase III multi-ins ...... ncreatic cancer: final results

@en

P2093

Aaron T Wild

http://www.w3.org/2001/XMLSchema#string

Alexander Rosemurgy

http://www.w3.org/2001/XMLSchema#string

Christopher L Wolfgang

http://www.w3.org/2001/XMLSchema#string

Daniel A Laheru

http://www.w3.org/2001/XMLSchema#string

Dionne T Savage

http://www.w3.org/2001/XMLSchema#string

Gretchen E Taylor

http://www.w3.org/2001/XMLSchema#string

Hao Wang

http://www.w3.org/2001/XMLSchema#string

Hongyan Cai

http://www.w3.org/2001/XMLSchema#string

Jason Klapman

http://www.w3.org/2001/XMLSchema#string

Joseph M Herman

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

Cancer statistics, 2012

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Cancer statistics, 2007

Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients.

Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer.

Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging.

Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation

P304

886-894

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2012.44.7516

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235363885

http://www.w3.org/2001/XMLSchema#string

P698

23341531

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

4820756

http://www.w3.org/2001/XMLSchema#string